Detalhe da pesquisa
1.
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.
ACS Med Chem Lett
; 13(8): 1248-1254, 2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35978682
2.
Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library.
Sci Rep
; 8(1): 585, 2018 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330364
3.
Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks.
Nat Genet
; 41(4): 415-23, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19270708
4.
Deficiency in cytosolic malic enzyme does not increase acetaminophen-induced hepato-toxicity.
Basic Clin Pharmacol Toxicol
; 103(1): 36-42, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18346052
5.
Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.
Obes Res
; 13(8): 1311-20, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16129712